Key Highlights
•
A new brain imaging biomarker, called the DLB-related pattern (DLBRP), can accurately diagnose dementia with Lewy bodies (DLB) and even detect the disease in its early, pre-dementia stage. This tool helps doctors distinguish DLB from Alzheimer’s disease, leading to more accurate diagnoses and better-targeted treatments for patients.
Source →
•
The sleep medication zolpidem was found to restore healthy sleep patterns and reduce the buildup of harmful amyloid plaques in the brains of mice engineered to develop Alzheimer’s disease. This suggests that improving sleep quality with certain medications could be a promising new strategy to slow the progression of Alzheimer’s in its early stages.
Source →
•
A smartphone app delivering cognitive behavioral therapy (CBT) helped reduce symptoms of depression in women who had experienced multiple pregnancy losses. While the app was helpful overall, no single component of the therapy (like problem-solving or changing negative thoughts) was more effective than the others, indicating the benefit may come from the structured support itself.
Source →
•
Researchers developed a new mathematical model that analyzes cancer spread on a lesion-by-lesion basis, revealing that tumors in different organs (like liver vs. bone) respond to therapy in distinct ways. This approach provides a more detailed picture of how cancer treatments work, which could lead to more personalized and effective treatment plans for patients.
Source →
•
The severity of bronchiolitis, a common respiratory infection in infants, is linked to dysregulation in the body’s immune checkpoints—the same systems targeted by modern cancer immunotherapies. This discovery opens the door to potentially using similar immune-modulating treatments to help children with severe cases of this illness.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
